Eli Lilly and Company (LLY) News
Eli Lilly and Company (LLY)
Today's Latest Price: $206.14 USD
Updated Jan 22 7:00pm
Add LLY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
StocksNews Articles for LLY
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest LLY News From Around the Web
Below are the latest news stories about ELI LILLY & Co that investors may wish to consider to help them evaluate LLY as an investment opportunity.
Antibody can prevent COVID-19 infection in nursing, LTC homes: drugmaker Eli LillyThe study, which was conducted with the National Institutes of Health, is the first major one to show such a treatment may prevent illness in a group devastated by the pandemic. |
LIVE: Jim Cramer on Amazon, Eli Lilly, Fuelcell, FAANG, Stock Market ThursdayIn Thursday's market breakdown, Jim Cramer talks airlines, Amazon, Eli Lilly, Fuelcell and more. |
Eli Lilly Says Covid-19 Treatment Reduces Risk for Nursing Home ResidentsEli Lilly says nursing home residents have an 80% lower risk of contracting Covid-19 compared with those who received a placebo. |
Women Health Market Impressive Growth 2021 to 2027 | Sanofi, Amgen, Eli Lilly and Company, Lupin PharmaceuticalsThe key market drivers for Women Health Market Includes, Increasing awareness about women health along with various R&D activities by research companies for proving better therapeutics and health care to women. Moreover, changes in lifestyle which leads to bad nutrition |
Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the risk of contracting COVID-19 significantly in nursing homes. […] The post Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80% first appeared on AlphaStreet . |
Testosterone Replacement Therapy Market 2021 Research Report, Latest Trend, Demands, Industry Growth, Size, Share, Top Key Players And Forecast 2027 | Allergan plc, Eli Lilly and Company, Endo Pharmaceuticals, Mylan N.V.Allied Market Research published a new report, titled, "Testosterone Replacement Therapy Market Global Opportunity Analysis and Industry Forecast, 2020-2027". The report has offered an all-inclusive analysis of the global Testosterone Replacement Therapy Market taking into consideration all the crucial aspects like |
STAT+: Pharmalittle: Lilly says its antibody prevented Covid-19 in a trial; EU and Pfizer clash over vaccine delaysEli Lilly says its monoclonal antibody prevented Covid-19 infections in nursing home residents and staff in a clinical trial, the first time such a treatment has been shown to prevent… |
Lilly: Drug can prevent COVID-19 illness in nursing homesDrugmaker Eli Lilly says its COVID-19 antibody drug can prevent illness among residents and staff of nurusing homes and other long-term care locations |
Eli Lilly antibody cuts COVID-19 risk up to 80% in nursing home studyEli Lilly’s antibody therapy reduced nursing home residents’ risk of symptomatic COVID-19 by as much as 80% when used preventively in a study and also significantly reduced the risk of symptomatic disease in nursing home workers |
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reportsA study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut risk of COVID-19 by up to 80%, maker Eli Lilly announced. |